ES252980A1 - Procedimiento para la obtencion de nuevas sales cuaternarias, terapéuticamente valiosas, de la normorfina y de sus derivados - Google Patents

Procedimiento para la obtencion de nuevas sales cuaternarias, terapéuticamente valiosas, de la normorfina y de sus derivados

Info

Publication number
ES252980A1
ES252980A1 ES0252980A ES252980A ES252980A1 ES 252980 A1 ES252980 A1 ES 252980A1 ES 0252980 A ES0252980 A ES 0252980A ES 252980 A ES252980 A ES 252980A ES 252980 A1 ES252980 A1 ES 252980A1
Authority
ES
Spain
Prior art keywords
normorphine
lower acyl
derivatives
radicalx
propyloalyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0252980A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Publication of ES252980A1 publication Critical patent/ES252980A1/es
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la obtención de nuevas sales cuaternariasterapéuticamente valiosasde la normorfina y respectivamente de sus derivados sustituidos por restos acilo inferiores en los dos átomos de oxígenode la fórmula general: **(Ver fórmula)** en la cual R representa hidrógeno o un resto acilo inferiorX representa clorobromo o yodoy R1 y R2 representan el resto propiloalilo o proparoilocaracterizado por el hecho de transformarse con halogenuros de propilode alilo o ...
ES0252980A 1958-10-30 1959-10-28 Procedimiento para la obtencion de nuevas sales cuaternarias, terapéuticamente valiosas, de la normorfina y de sus derivados Expired ES252980A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE874217X 1958-10-30

Publications (1)

Publication Number Publication Date
ES252980A1 true ES252980A1 (es) 1960-11-01

Family

ID=6816813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0252980A Expired ES252980A1 (es) 1958-10-30 1959-10-28 Procedimiento para la obtencion de nuevas sales cuaternarias, terapéuticamente valiosas, de la normorfina y de sus derivados

Country Status (2)

Country Link
ES (1) ES252980A1 (es)
GB (1) GB874217A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009023567A1 (en) 2007-08-09 2009-02-19 Rensselaer Polytechnic Institute Quaternary opioid carboxamides
HUE043963T2 (hu) 2009-12-04 2019-09-30 Alkermes Pharma Ireland Ltd Morfinán származékok gyógyszer-túladagolás kezelésére
WO2011119605A2 (en) 2010-03-22 2011-09-29 Rensselaer Polytechnic Institute Carboxamide biosiosteres of opiates
EP2608670B1 (en) 2010-08-23 2018-10-31 Alkermes Pharma Ireland Limited Methods for treating antipsychotic-induced weight gain
CA2840643C (en) 2011-06-29 2017-11-21 Alkermes, Inc. Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
ES2770978T3 (es) 2013-05-24 2020-07-06 Alkermes Pharma Ireland Ltd Análogos de morfanos y morfinanos y métodos de uso
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Also Published As

Publication number Publication date
GB874217A (en) 1961-08-02

Similar Documents

Publication Publication Date Title
ES406891A1 (es) Procedimiento para la obtencion de una composicion suaviza-dora antiestatica.
GB874217A (en) Normorphine derivatives
GB1041536A (en) Quaternary ammonium derivatives of dibenzo[a,d]-cycloheptadiene derivatives
GB1181322A (en) Piperazine Derivatives and processes for preparing the same
GB966852A (en) Herbicides
GB933155A (en) Improvements in or relating to steroids
GB984361A (en) Pharmaceutical compositions containing quaternary ammonium salts
GB1214734A (en) Quarternary ammonium compounds preparation thereof and biocidal compositions comprising same
GB922321A (en) Improvements in and relating to quaternary ammonium compounds and the preparation thereof
ES361551A1 (es) Procedimiento para la obtencion de agentes para combatir los hongos del moho.
GB985970A (en) Diaminoanthraquinones
GB1183636A (en) Alkylation of Aralkyl Tertiary Amines
GB1021522A (en) 2-quinolone derivatives
GB1163921A (en) Azadibenzocycloheptene Derivatives
GB890533A (en) Improvements in or relating to heterocyclic quaternary ammonium salts
GB1019462A (en) Improvements in or relating to novel 3-azabicyclo-[3.2.2]-nonane derivatives
GB875955A (en) Triphenylalkylamines and stimulant compositions containing them
GB1266660A (es)
GB978281A (en) Tetrahydro-and decahydro-isoquinolinium compounds
GB843908A (en) Novel morphinan derivatives and the manufacture thereof
GB595243A (en) Improvements in compositions toxic to lower forms of life
GB954243A (en) Improvements in or relating to acetylenic compounds
GB910999A (en) 16,17ª--oxido-21-aminoalkyl-í~-pregnen-3ª--ol-20-one compounds
GB1021530A (en) Derivatives of 2-oxo-2h-1,4-benzoxazine
GB850930A (en) Bis-quaternary phenanthridinium salts